156 related articles for article (PubMed ID: 24582052)
1. Long-term survival of patients with pN2 lung cancer according to the pattern of lymphatic spread.
Legras A; Mordant P; Arame A; Foucault C; Dujon A; Le Pimpec Barthes F; Riquet M
Ann Thorac Surg; 2014 Apr; 97(4):1156-62. PubMed ID: 24582052
[TBL] [Abstract][Full Text] [Related]
2. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
[TBL] [Abstract][Full Text] [Related]
3. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
4. Re-appraisal of N2 disease by lymphatic drainage pattern for non-small-cell lung cancers: by terms of nodal stations, zones, chains, and a composite.
Zheng H; Wang LM; Bao F; Jiang GN; Xie HK; Ding JA; Hu XF; Chen C
Lung Cancer; 2011 Dec; 74(3):497-503. PubMed ID: 21529990
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors after surgical resection of N1 non-small cell lung cancer.
Mordant P; Pricopi C; Legras A; Arame A; Foucault C; Dujon A; Le Pimpec-Barthes F; Riquet M
Eur J Surg Oncol; 2015 May; 41(5):696-701. PubMed ID: 25454825
[TBL] [Abstract][Full Text] [Related]
6. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
8. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
9. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
10. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
[TBL] [Abstract][Full Text] [Related]
12. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.
Misthos P; Sepsas E; Athanassiadi K; Kakaris S; Skottis I
Eur J Cardiothorac Surg; 2004 Apr; 25(4):502-8. PubMed ID: 15037262
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for survival in patients with completely resected pN2 non-small-cell lung cancer.
Sezen CB; Aksoy Y; Sonmezoglu Y; Citak N; Saydam O; Metin M
Acta Chir Belg; 2021 Feb; 121(1):23-29. PubMed ID: 31437115
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
15. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
18. Is video-assisted thoracoscopic surgery a feasible approach for clinical N0 and postoperatively pathological N2 non-small cell lung cancer?
Watanabe A; Mishina T; Ohori S; Koyanagi T; Nakashima S; Mawatari T; Kurimoto Y; Higami T
Eur J Cardiothorac Surg; 2008 May; 33(5):812-8. PubMed ID: 18342533
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
